Home Cart Sign in  
Chemical Structure| 1353644-70-8 Chemical Structure| 1353644-70-8

Structure of Theliatinib
CAS No.: 1353644-70-8

Chemical Structure| 1353644-70-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Theliatinib, is a small molecule, epidermal growth factor receptor tyrosine kinase inhibitor with potential antineoplastic and anti-angiogenesis activities.

Synonyms: Xiliertinib; HMPL-309; xiliertinibum

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Theliatinib

CAS No. :1353644-70-8
Formula : C25H26N6O2
M.W : 442.51
SMILES Code : O=C(N1C[C@]2([H])N(C)CC[C@]2([H])C1)NC3=CC4=C(NC5=CC=CC(C#C)=C5)N=CN=C4C=C3OC
Synonyms :
Xiliertinib; HMPL-309; xiliertinibum
MDL No. :MFCD32173988

Safety of Theliatinib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of Theliatinib

RTK
JAK-STAT

Isoform Comparison

Biological Activity

Target
  • EGFR/ErbB1

    WT EGFR, IC50:3 nM

  • mutant EGFR

    EGFR T790M/L858R, IC50:22 nM

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02601274 Cancer PHASE1 TERMINATED 2025-12-18 Beijing Cancer Hospital, Beiji... More >>ng, Beijing, China|Sun-Yat-sen univercity cancer centre, Guangzhou, Guangdong, 510060, China Less <<
NCT02601248 Cancer PHASE1 COMPLETED 2025-05-16 Tianjin Cancer Hospital, Tianj... More >>in, 300060, China Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.26mL

0.45mL

0.23mL

11.30mL

2.26mL

1.13mL

22.60mL

4.52mL

2.26mL

References

 

Historical Records

Categories